✦ LIBER ✦

Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine

✍ Scribed by Juan, O.; Vidal, J.; Gisbert, R.; Muñoz, J.; Maciá, S.; Gómez-Codina, J.

Book ID: 121604716
Publisher: Springer Milan
Year: 2013
Tongue: Spanish
Weight: 264 KB
Volume: 16
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-013-1128-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation and Prognostic Significance o

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer

✍ Krebs, M. G.; Sloane, R.; Priest, L.; Lancashire, L.; Hou, J.-M.; Greystoke, A.; 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Prognostic and predictive relevance of c

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer

✍ Alama, Angela; Truini, Anna; Coco, Simona; Genova, Carlo; Grossi, Francesco 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 606 KB

Chemotherapy-induced neutropenia as a pr

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

✍ Pallis, A.G.; Agelaki, S.; Kakolyris, S.; Kotsakis, A.; Kalykaki, A.; Vardakis, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Gemcitabine and Carboplatin for Patients

Gemcitabine and Carboplatin for Patients With Advanced Non-Small Cell Lung Cancer

✍ Manuel Dómine; Victoria Casado; Laura G. Estévez; Ana León; Jose Ignacio Martin; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Prognostic significance of RASSF1A promo

Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine

✍ Fischer, Jürgen R.; Ohnmacht, Ute; Rieger, Norman; Zemaitis, Marius; Stoffregen, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 919 KB

Phase II Study of Cetuximab, Docetaxel,

Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

✍ David R. Spigel; F. Anthony Greco; Dana S. Thompson; Charles Webb; James Rubinsa 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB